SAFETY AND EFFICACY OF LONG-TERM SUBCUTANEOUS Cl-INHIBITOR REPLACEMENT THERAPY FOR PREVENTION OF HEREDITARY ANGIOEDEMA ATTACKS

被引：2
|
作者：
Craig, T.
Longhurst, H.
Cicardi, M.
Zuraw, B.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.107
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P159
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
    Riedl, Marc A.
    Bernstein, Jonathan A.
    Craig, Timothy
    Banerji, Aleena
    Magerl, Markus
    Cicardi, Marco
    Longhurst, Hilary J.
    Shennak, Mustafa M.
    Yang, William H.
    Schranz, Jennifer
    Baptista, Jovanna
    Busse, Paula J.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2017, 7
  • [22] ATTACKS AVOIDED AND COST OFFSETS ASSOCIATED WITH SUBCUTANEOUS C1-INHIBITOR (HUMAN) LONG-TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA
    Graham, C.
    Machnig, T.
    Knox, H.
    Supina, D.
    Krishnarajah, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S40 - S41
  • [23] LONG-TERM THERAPY OF HEREDITARY ANGIOEDEMA WITH DANAZOL
    HOSEA, SW
    SANTAELLA, ML
    BROWN, EJ
    BERGER, M
    KATUSHA, K
    FRANK, MM
    ANNALS OF INTERNAL MEDICINE, 1980, 93 (06) : 809 - 812
  • [24] LONG-TERM EFFICACY OF SUBCUTANEOUS C1-INHIBITOR IN PATIENTS WITH HEREDITARY ANGIOEDEMA AND VERY HIGH ATTACK BURDEN
    Zuraw, Bruce
    Craig, Timothy
    Cicardi, Marco
    Longhurst, Hilary
    Feuersenger, Henrike
    Prusty, Subhransu
    Katelaris, Constance
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 27 - 28
  • [25] Long-term efficacy and safety of lanadelumab by baseline attack rates in hereditary angioedema
    Banerji, Aleena
    Riedl, Marc
    Tachdjian, Raffi
    Nurse, Christina
    Yu, Ming
    Kiani, Sorena
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB24 - AB24
  • [26] Testosterone Replacement Therapy: Long-Term Safety and Efficacy
    Corona, Giovanni
    Sforza, Alessandra
    Maggi, Mario
    WORLD JOURNAL OF MENS HEALTH, 2017, 35 (02): : 65 - 76
  • [27] Durability of symptom control with long-term prophylactic therapy with subcutaneous C1-inhibitor in patients with hereditary angioedema
    Craig, Timothy
    Feuersenger, Henrike
    Pragst, Ingo
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (06) : 458 - 459
  • [28] Long-term efficacy and safety of subcutaneous garadacimab for prophylaxis of hereditary angioedema attacks: Results from a multicentre phase 3 study and open-label extension
    Magerl, M.
    Reshef, A.
    Farkas, H.
    Li, H. H.
    Jacobs, J. S.
    Bernstein, J.
    Yang, W.
    Stroes, E. S.
    Ohsawa, I.
    Tachdjian, R.
    Manning, M. E.
    Lumry, W. R.
    Saguer, I. Martinez
    Aygoeren-Puersuen, E.
    Ritchie, B.
    Sussman, G. L.
    Anderson, J.
    Kawahata, K.
    Suzuki, Y.
    Staubach, P.
    Treudler, R.
    Feuersenger, H.
    Jacobs, I.
    Craig, T. J.
    ALLERGY, 2023, 78 : 115 - 117
  • [29] THE LONG-TERM SAFETY OF DANAZOL IN WOMEN WITH HEREDITARY ANGIOEDEMA
    ZURLO, JJ
    FRANK, MM
    FERTILITY AND STERILITY, 1990, 54 (01) : 64 - 72
  • [30] Long-term efficacy of danazol treatment in hereditary angioedema
    Fuest, George
    Farkas, Henriette
    Csuka, Dorottya
    Varga, Lilian
    Bork, Konrad
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (03) : 256 - 262
12345